Role of Infection in Atherosclerosis and Coronary Artery Disease: A New Therapeutic Target?
- 1 July 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 10 (4) , 199-210
- https://doi.org/10.1097/00045415-200207000-00004
Abstract
There is growing evidence that inflammatory processes may be involved in the development of atherosclerosis and its complications. Viral and bacterial pathogens have been implicated as possible causative factors in the pathogenesis of coronary artery disease and postangioplasty restenosis. Antibiotic trials have been completed examining which treatment of infection can prevent the complications of coronary artery disease. In high-risk patients, the results of these most recent studies have not revealed any benefit of treatment.Keywords
This publication has 92 references indexed in Scilit:
- Epstein-Barr virus genes and cancer cellsBiomedicine & Pharmacotherapy, 1997
- Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosisAmerican Heart Journal, 1996
- Cardiac allograft vasculopathy: Current conceptsAmerican Heart Journal, 1995
- Dental infections and coronary atherosclerosisAtherosclerosis, 1993
- Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in FinlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Plasma Triglyceride Level and Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Viral coronary arteritis and myocardial infarctionAmerican Heart Journal, 1976